PMC:7696151 / 116260-116918 JSON TXT

Annnotations TAB JSON ListView MergeView

Id	Subject	Object	Predicate	Lexical cue	tao:has_database_id
4103	78-86	Species	denotes	patients	Tax:9606
4104	220-228	Species	denotes	patients	Tax:9606
4105	508-516	Species	denotes	patients	Tax:9606
4106	570-577	Species	denotes	patient	Tax:9606
4150	639-642	Chemical	denotes	HCQ	MESH:D006886
4220	60-68	Disease	denotes	COVID-19	MESH:C000657245
4221	69-77	Disease	denotes	infected	MESH:D007239
4222	211-219	Disease	denotes	infected	MESH:D007239
4223	426-431	Disease	denotes	death	MESH:D003643
4224	541-565	Disease	denotes	QT interval prolongation	MESH:D008133

Id	Subject	Object	Predicate	Lexical cue	hp_id
T277	378-398	Phenotype	denotes	respiratory distress	http://purl.obolibrary.org/obo/HP_0002098

Id	Subject	Object	Predicate	Lexical cue
T776	0-658	Sentence	denotes	Mahévas, et al. (2020) [38] No-randomize clinical study181 COVID-19 infected patients HCQ group -> 600 mg/day for 5 days (n = 84) within 48 h of admission to hospitalControl group (n = 97) Within day 7:20.2% infected patients of the HCQ group and 22.1% in the control group died or were transferred to the ICU;27.4% of the HCQ group and 24.4% of the no-HCQ group shown acute respiratory distress;On day 7 the percentage of death was similar in both HCQ and control group (2.8 vs. 4.8%, 3 vs. 4 events) 7 patients of the HCQ group showed QT interval prolongation.One patient presented first-degreeatrioventricular block after 2 days of HCQ administration.